-
-
-
-
-
-
-
Form S-1/A LIXTE BIOTECHNOLOGY HOLD
-
-
-
-
-
-
-
Lixte Biotechnology Holdings, Inc. Announces Pricing of $5,700,000 Public Offering; Uplisting to Nasdaq Capital Market and Reverse Stock Split
-
-
-
-
-
66,422 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

